Literature DB >> 7395960

Falciform fold, retinal detachment, and Norrie's disease.

H N Jacklin.   

Abstract

A patient with X-chromosome-linked recessive Norrie's disease, characterized by retinal falciform fold, retinal detachment, repeated vitreous hemorrhage, and retrolental membrane formation, was observed from age 6 weeks. The patient showed the clinical progression from these early retinal and vitreous changes to the more typical retrolental vascularized detached retina. Pathologic examination showed normal retinal tissue. Two other male relatives showed the end stages of Norrie's disease with bilateral congenital blindness, with and without mental retardation and deafness. Vitreoretinal surgery prevented phthisis bulbi from occurring the operated eye but was unsuccessful in reattaching the contracted retina.

Entities:  

Mesh:

Year:  1980        PMID: 7395960     DOI: 10.1016/s0002-9394(14)75079-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

1.  The ocular pathology of Norrie disease in a fetus of 11 weeks' gestational age.

Authors:  M A Parsons; D Curtis; C E Blank; H N Hughes; A C McCartney
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

2.  Linkage analysis of Norrie disease with X-chromosomal ornithine aminotransferase.

Authors:  J B Bateman
Journal:  Trans Am Ophthalmol Soc       Date:  1992

3.  Dominant exudative vitreoretinopathy and other vascular developmental disorders of the peripheral retina.

Authors:  C E van Nouhuys
Journal:  Doc Ophthalmol       Date:  1982-09-23       Impact factor: 2.379

4.  Congenital retinal fold as a sign of dominant exudative vitreoretinopathy.

Authors:  C E van Nouhuys
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

5.  Probably Norrie's disease due to mutation. Two sporadic sibships of two males each, a necropsy of one case, and, given Norrie's disease, a calculation of the gene mutation frequency.

Authors:  C I Phillips; M Newton; J Duvall; S Holloway; A M Levy
Journal:  Br J Ophthalmol       Date:  1986-04       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.